MedPath
HSA Approval

RHEWLIN FORTE TABLETS 50 mg

SIN05560P

RHEWLIN FORTE TABLETS 50 mg

RHEWLIN FORTE TABLETS 50 mg

March 7, 1991

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

M01AB05

diclofenac

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

DICLOFENAC SODIUM

50 mg

Diclofenac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RHEWLIN FORTE TABLETS 50 mg - HSA Approval | MedPath